Enter your login e-mail to the account
Search
Search parameters
Search results
- Nová perorální antidiabetika
doc. MUDr. Tomáš Sechser, CSc.
(1/2004, clearly ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Osteoporóza a diabetes mellitus
prof. MUDr. Juraj Payer, CSc., MUDr. Peter Jackuliak, PhD.
(3–4/2013, Topic ) - Exsudate in chronic wound – its management and an appropriate choice of wound dressings
MUDr. Júlia Stracenská
(2/2011, Interdisciplinary consilium ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - Retardované mononitráty v klinické praxi
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Spectrum ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - SPRÁVA Z V. SYMPÓZIA „ARTÉRIOVÁ HYPERTENZIA: SÚČASNÉ KLINICKÉ TRENDY“, 3. APRÍL 2007, PRAHA (1. časť)
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(6/2007, Events ) - NOVEL INSULINS – ANALOGS IN TYPE 2 DM TREATMENT
doc. MUDr. Emil Martinka, PhD.
(7-8/2008, Topic ) - Effective drug therapy of liver diseases in general practice
doc. MUDr. Radan Brůha, CSc.
(1/2014, Review articles ) - SPRÁVA Z XVIII. DIABETOLOGICKÝCH DNÍ 28. – 30. MÁJ 2008, KOŠICE
MUDr. Slávka Kalinová, PhD.
(7-8/2008, Events ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles )
- NOVÁ DOPORUČENÍ (GUIDELINES) PRO LÉČBU DIABETES MELLITUS 2. TYPU
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2007, clearly ) - Perorální antidiabetika – současnost
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2009, Drugs & drug classes ) - DIABETES MELLITUS TYPE 2 TREATMENT – ORAL ANTIDIABETIC AGENTS
MUDr. Pavlína Piťhová
(2/2007, clearly )
- The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy ) - Starostlivosť lekárnika o pacientov s diabetom
PharmDr. Marcel Jusko, PhD.
(2/2013, For pharmaceutical laboratory technicians )